Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2026-01-05 @ 3:11 AM
Study NCT ID:
NCT00170456
Status:
COMPLETED
Last Update Posted:
2008-09-15
First Post:
2005-09-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase II Study of Range and Schedule of rPA Doses
Sponsor:
PharmAthene UK Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
05-0003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |